Katarzyna Karlowicz

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Multicentre retrospective real-world evidence study evaluating the effectiveness and safety of mirikizumab in patients with moderately to severely active ulcerative colitis.

Multicentre retrospective real-world evidence study evaluating the effectiveness and safety of mirikizumab in patients with moderately to severely active ulcerative colitis.

Journal: Przeglad gastroenterologiczny

Published: March 30, 2026

A comprehensive review of usefulness of sodium butyrate for the management of inflammatory bowel disease: from molecular mechanisms to clinical application.

A comprehensive review of usefulness of sodium butyrate for the management of inflammatory bowel disease: from molecular mechanisms to clinical application.

Journal: Przeglad gastroenterologiczny

Published: January 21, 2026

RESCUE-CD - Real-world effectiveness of risankizumab in moderate-to-severe Crohn's disease: a case series involving the most refractory and challenging patients.

RESCUE-CD - Real-world effectiveness of risankizumab in moderate-to-severe Crohn's disease: a case series involving the most refractory and challenging patients.

Journal: Przeglad gastroenterologiczny

Published: January 08, 2026

Efficacy of Microencapsulated Sodium Butyrate as Add-On Therapy in Inducing Remission in Patients with Mild-To-Moderate Ulcerative Colitis: Results From a Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.

Efficacy of Microencapsulated Sodium Butyrate as Add-On Therapy in Inducing Remission in Patients with Mild-To-Moderate Ulcerative Colitis: Results From a Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: December 21, 2025

Fecal butyric acid as a predictive biomarker of endoscopic remission in inflammatory bowel disease: a multicenter prospective study.

Fecal butyric acid as a predictive biomarker of endoscopic remission in inflammatory bowel disease: a multicenter prospective study.

Journal: Przeglad gastroenterologiczny

Published: July 14, 2025

Clinical Response and Improvement of the Quality of Life, Fatigue, Mood, and Sleep Disturbances During Vedolizumab Induction Therapy in Polish Patients With Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.

Clinical Response and Improvement of the Quality of Life, Fatigue, Mood, and Sleep Disturbances During Vedolizumab Induction Therapy in Polish Patients With Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.

Journal: Canadian journal of gastroenterology & hepatology

Published: May 19, 2025

Response.

Response.

Journal: Gastrointestinal endoscopy

Published: March 27, 2025

Risk factors for difficult endoscopic bowel dilation of predominantly shorter and noninflammatory strictures among patients with inflammatory bowel disease: findings from inflammatory bowel disease tertiary centers in Poland and Czech Republic.

Risk factors for difficult endoscopic bowel dilation of predominantly shorter and noninflammatory strictures among patients with inflammatory bowel disease: findings from inflammatory bowel disease tertiary centers in Poland and Czech Republic.

Journal: Gastrointestinal endoscopy

Published: October 27, 2024

Ophthalmological manifestations in inflammatory bowel disease under the watchful eye of a gastroenterologist from a tertiary centre.

Ophthalmological manifestations in inflammatory bowel disease under the watchful eye of a gastroenterologist from a tertiary centre.

Journal: Przeglad gastroenterologiczny

Published: September 05, 2024

SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients - does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective study.

SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients - does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective study.

Journal: Przeglad gastroenterologiczny

Published: April 25, 2023

Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel Disease.

Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel Disease.

Journal: Journal of personalized medicine

Published: April 21, 2023

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome.

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome.

Journal: Przeglad gastroenterologiczny

Published: December 04, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026